Clincosm LogoSign in Get a demo

adenocarcinoma

Showing 51 - 75 of 170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Carcinoma, Adenocarcinoma, Esophageal Cancer Trial in Amsterdam (Carboplatin, Paclitaxel, panitumumab)

Completed
  • Squamous Cell Carcinoma
  • +3 more
  • Amsterdam, Netherlands
    Academic Medical Center
Apr 19, 2021

Uterine Cervical Tumors, Squamous Cell Carcinoma, Adenocarcinoma Trial in Canada (Metformin, Cisplatin, FAZA)

Completed
  • Uterine Cervical Neoplasms
  • +3 more
  • Calgary, Alberta, Canada
  • +4 more
Apr 19, 2021

Adenocarcinoma Trial in Chicago (Trastuzumab, ABT-806, Bemarituzumab)

Completed
Has Results
  • Adenocarcinoma
  • Chicago, Illinois
    University of Chicago
Mar 15, 2021

Next Generation Sequencing of Tumor Cells in Locally Advanced

Completed
  • Adenocarcinoma
  • Biopsy EUS guided
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Mar 17, 2021

Adenocarcinoma Trial in Fuenlabrada, Madrid, Zaragoza (Personalised treatment, Treatment chosen per investigator´s judge)

Unknown status
  • Adenocarcinoma
  • Personalised treatment
  • Treatment chosen per investigator´s judge
  • Fuenlabrada, Madrid, Spain
  • +4 more
Feb 24, 2021

Cervical Squamous Cell Carcinoma, Adenosquamous Carcinoma, Adenocarcinoma Trial in Houston, Brussels (Extraperitoneal

Completed
Has Results
  • Cervical Squamous Cell Carcinoma
  • +4 more
  • Extraperitoneal laparoscopic lymphadenectomy (EPLND)
  • Chemoradiation
  • Houston, Texas
  • +2 more
Jan 13, 2021

Adenocarcinoma Trial (Laparoscopic Esophagectomy)

Withdrawn
  • Adenocarcinoma
  • Laparoscopic Esophagectomy
  • (no location specified)
Jan 22, 2021

Adenocarcinoma Trial in Bron (Thrombin Generation Assay)

Recruiting
  • Adenocarcinoma
  • Thrombin Generation Assay
  • Bron, France
    Unité d'Hémostase Clinique Hôpital Louis Pradel
Jan 5, 2021

Adenocarcinoma Trial in Denmark (Docetaxel, Oxaliplatin, Capecitabine)

Completed
  • Adenocarcinoma
  • Aalborg, Denmark
  • +3 more
Oct 29, 2020

Pancreatic Tumors, Adenocarcinoma Trial in Houston (Curcumin)

Completed
Has Results
  • Pancreatic Neoplasms
  • Adenocarcinoma
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 13, 2020

Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen.

Completed
  • Adenocarcinoma
  • Immunotherapeutic Agents
  • Ablation
  • Fort Lauderdale, Florida
    The Center for High Risk and Recurrent Prostate Cancer
Jul 21, 2020

Stomach Tumor, GastroEsophageal Cancer, Adenocarcinoma Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Stomach Neoplasm
  • +4 more
  • Tegafur-Gimeracil-Oteracil Potassium
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 2, 2020

Breast Cancer, Pancreatic Cancer, Colorectal Cancer Trial in Oklahoma City, Nashville (MORAb-066)

Completed
  • Breast Cancer
  • +5 more
  • Oklahoma City, Oklahoma
  • +1 more
Apr 14, 2020

Peritoneal Tumors, Tumor Metastasis, Adenocarcinoma Trial in Elmhurst, Naperville

Completed
  • Peritoneal Neoplasms
  • +3 more
    • Elmhurst, Illinois
    • +1 more
    Jan 27, 2020

    Cervical Cancer, Squamous Cell Carcinoma, Adenosquamous Carcinoma Trial in Canada (CT Abdomen and Pelvis scan + whole body

    Completed
    • Cervical Cancer
    • +3 more
    • CT Abdomen and Pelvis scan + whole body PET-CT scan
    • CT Abdomen and Pelvis scan
    • Hamilton, Ontario, Canada
    • +5 more
    Jan 28, 2020

    Neoadjuvant Chemoradiotherapy for Rectal Cancer

    Unknown status
    • Rectal Neoplasm Malignant Carcinoma
    • +4 more
    • Radiation
    • Capecitabine-Irinotecan Combination
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jan 11, 2020

    Adenocarcinoma Trial in San Francisco (PEGPH20, Gemcitabine, Nab-paclitaxel)

    Terminated
    Has Results
    • Adenocarcinoma
    • San Francisco, California
      University of California, San Francisco
    Dec 16, 2019

    Carcinoma, Non-Small Cell Lung, Adenocarcinoma, Carcinoma, Squamous Cell Trial run by the NCI (PF-02341066/PF-00299804)

    Terminated
    • Carcinoma, Non-Small Cell Lung
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 14, 2019

    Adenocarcinoma, NSCLC Trial in Boston (Erlotinib)

    Completed
    Has Results
    • Adenocarcinoma
    • Non-small Cell Lung Cancer
    • Boston, Massachusetts
    • +2 more
    Dec 7, 2019

    Adenocarcinoma, Circulating Tumor Cells, Pancreatic Tumors Trial in Switzerland (Desflurane)

    Completed
    • Adenocarcinoma
    • +2 more
    • St. Gallen, Switzerland
    • +3 more
    Dec 12, 2019

    Gastric Cancer, Adenocarcinoma Trial in Worldwide (biological, drug, other)

    Completed
    Has Results
    • Gastric Cancer
    • Adenocarcinoma
    • ramucirumab
    • +2 more
    • Bakersfield, California
    • +160 more
    Sep 10, 2019

    Lung Cancer, Adenocarcinoma Trial in Tampa (Phase I - GM.CD40L.CCL21 Vaccinations, Phase II - GM.CD40L cells Vaccinations, Phase

    Completed
    Has Results
    • Lung Cancer
    • Adenocarcinoma
    • Phase I - GM.CD40L.CCL21 Vaccinations
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Aug 5, 2019

    Lung Cancer, Adenocarcinoma, NSCLC Trial in Germany, Spain, Switzerland (Crizotinib)

    Unknown status
    • Lung Cancer
    • +2 more
    • Heidelberg, Baden-Würtemberg, Germany
    • +17 more
    Jul 11, 2019

    Breast Tumors, Carcinoma, Ductal, Adenocarcinoma Trial in Baltimore (Active Breathing Coordinator)

    Completed
    Has Results
    • Breast Neoplasms
    • +2 more
    • Active Breathing Coordinator
    • Baltimore, Maryland
      The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    May 24, 2019

    Tumors, Lymphoma, Adenocarcinoma Trial in Kashiwa, Matsuyama, Tokyo (Part 1: JNJ-42756493, Part 2: JNJ-42756493)

    Completed
    • Neoplasms
    • +3 more
    • Part 1: JNJ-42756493
    • Part 2: JNJ-42756493
    • Kashiwa, Japan
    • +2 more
    May 13, 2019